USANA Health Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Quarterly Financial Results

Quarterly Financial Results

12 Months Ended

Dec. 28, 2013

Quarterly Financial Results [Abstract]

Quarterly Financial Results

NOTE – QUARTERLY FINANCIAL RESULTS (Unaudited)

The following table summarizes quarterly financial information for fiscal years 2012 and 2013.


2012	First	Second	Third	Fourth

Net sales	$ 154,120	$ 160,901	$ 165,175	$ 168,530

Gross profit	$ 126,903	$ 132,828	$ 134,832	$ 138,359

Net earnings	$ 13,751	$ 16,745	$ 17,490	$ 18,447

Earnings per share:
Basic	$ 0.92	$ 1.14	$ 1.22	$ 1.30
Diluted	$ 0.90	$ 1.11	$ 1.18	$ 1.27

2013	First	Second	Third	Fourth

Net sales	$ 169,082	$ 189,136	$ 173,691	$ 186,266

Gross profit	$ 138,821	$ 157,231	$ 142,200	$ 152,488

Net earnings	$ 17,779	$ 24,210	$ 16,753	$ 20,282

Earnings per share:
Basic	$ 1.30	$ 1.79	$ 1.22	$ 1.46
Diluted	$ 1.28	$ 1.72	$ 1.16	$ 1.41

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References + Details